When the diagnostic performance of those biomarkers was evaluated, we found an excellent diagnostic value of both MTA2 and AGO2, with high sensitivity and specificity, to discriminate patients with MM from normal individuals. The gene discussed is AGO2; the disease is Miyoshi myopathy.